131I therapy
Sponsors
Children's Hospital of Philadelphia
Conditions
CancerCancer, ThyroidDifferentiated Thyroid CancerPediatric Cancer
Phase 2
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RecruitingNCT05783323
Start: 2024-02-14End: 2027-10-01Target: 13Updated: 2025-11-14
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
RecruitingNCT06458036
Start: 2024-07-29End: 2031-11-01Target: 13Updated: 2026-07-24